Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ABBV-184 |
Trade Name | |
Synonyms | ABBV184|ABBV 184 |
Drug Descriptions |
ABBV-184 is a bispecific molecule that targets survivin and CD3, which crosslinks survivin-expressing tumor cells and lymphocytes, potentially leads to T-cell mediated killing of tumor cells (PMID: 37294945). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C175601 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ABBV-184 | ABBV-184 | 0 | 1 |